1/1
5 files

Treatment Patterns and Outcomes for Patients with Newly Diagnosed Glioblastoma Multiforme: A Retrospective Cohort Study: Supplementary Figure 1–2 and Supplementary Table 1–2

dataset
posted on 06.08.2021, 09:15 by Srinivas Annavarapu, Anagha Gogate, Trang Pham, Kalatu Davies, Prianka Singh, Nicholas Robert

Supplementary Table 1. First-line treatment-related AE for patients with GBM by MGMT testing status and MGMT methylation status

Supplementary Table 2. HCRU for patients with GBM by MGMT testing status, methylation status

Supplementary Figure 1. Kaplan-Meier curves and estimates for duration of treatment (a) by testing status (b) by methylation status

Supplementary Figure 2. K-M Curves and Estimates for Overall Survival from 1L Treatment Initiation for Patients with GBM by MGMT Testing Status and MGMT Methylation Status and Prior Steroid Use

(a) K-M Curve for Overall Survival from 1L Treatment Initiation for Not tested/Indeterminate Patients with GBM by Prior Steroid Use

(b) K-M Estimates Overall Survival from 1L Treatment Initiation for Not tested/Indeterminate Patients with GBM by Prior Steroid Use

(c). K-M Curve for Overall Survival from 1L Treatment Initiation for Methylated Patients with GBM by Prior Steroid Use

(d) K-M Estimates Overall Survival from 1L Treatment Initiation for Methylated Patients with GBM by Prior Steroid Use

(e) K-M Curve for Overall Survival from 1L Treatment Initiation for Unmethylated Patients with GBM by Prior Steroid Use

(f) K-M Estimates Overall Survival from 1L Treatment Initiation for Unmethylated Patients with GBM by Prior Steroid Use

Supplementary Figure 3. K-M Curve for Progression Free Survival from 1L Treatment Initiation for Patients with GBM by MGMT Testing Status and MGMT Methylation Status and Prior Steroid Use

(a) K-M Curve for Progression Free Survival from 1L Treatment Initiation for Not tested/Indeterminate Patients with GBM by Prior Steroid Use

(b) K-M Estimates Progression Free Survival from 1L Treatment Initiation for Not tested/Indeterminate Patients with GBM by Prior Steroid Use

(c) K-M Curve for Progression Free Survival from 1L Treatment Initiation for Methylated Patients with GBM by Prior Steroid Use

(d) K-M Estimates Progression Free Survival from 1L Treatment Initiation for Methylated Patients with GBM by Prior Steroid Use

(e) K-M Curve for Progression Free Survival from 1L Treatment Initiation for Unmethylated Patients with GBM by Prior Steroid Use

(f) K-M Estimates Progression Free Survival from 1L Treatment Initiation for Unmethylated Patients with GBM by Prior Steroid Use



Funding

Bristol-Myers Squibb

History